SCHEMBL2926136

SCHEMBL2926136

CCCCCCCC(C=O)CCCC

nearest known ligand 0.70

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
TSHR P16473 3/20 0.70
SMN1; SMN2 Q16637 1/20 0.70
ADH1B P00325 2/20 0.48
ADH1C P00326 2/20 0.48
ADH1A P07327 2/20 0.48
ADH4 P08319 2/20 0.48
ADH7 P40394 2/20 0.48
DNM1 Q05193 2/20 0.46
CA2 P00918 1/20 0.43
MAPT P10636 2/20 0.42
TRPA1 O75762 1/20 0.42
DDAH1 O94760 1/20 0.42
GAPDH P04406 1/20 0.42
FDPS P14324 4/20 0.41
GPR84 Q9NQS5 3/20 0.41
FFAR1 O14842 1/20 0.41
EPHX1 P07099 1/20 0.41
LMNA P02545 1/20 0.41
THRB P10828 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2920547 1.00 TSHR (0.70) TSHRSMN1; SMN2ADH1BADH1CADH1A
SCHEMBL9257929 1.00 TSHR (0.70) TSHRSMN1; SMN2ADH1BADH1CADH1A
SCHEMBL10403846 1.00 TSHR (0.70) TSHRSMN1; SMN2ADH1BADH1CADH1A
SCHEMBL29291467 1.00 TSHR (0.70) TSHRSMN1; SMN2ADH1BADH1CADH1A
SCHEMBL9714408 1.00 TSHR (0.70) TSHRSMN1; SMN2ADH1BADH1CADH1A
SCHEMBL729815 1.00 TSHR (0.70) TSHRSMN1; SMN2ADH1BADH1CADH1A
SCHEMBL29291473 1.00 TSHR (0.70) TSHRSMN1; SMN2ADH1BADH1CADH1A
SCHEMBL28418848 1.00 TSHR (0.70) TSHRSMN1; SMN2ADH1BADH1CADH1A
SCHEMBL10491642 1.00 TSHR (0.70) TSHRSMN1; SMN2ADH1BADH1CADH1A
SCHEMBL7772441 0.98 TSHR (0.67) TSHRSMN1; SMN2ADH1BADH1CADH1A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 78 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4622618-B1 PERSONAL CARE COMPOSITIONS FOR CLEANSING THE SKIN PROCTER & GAMBLE (US) 2026-04-22 EP disclosed
WO-2025245043-A1 BRANCHED DERIVATIVES SCION Holdings LLC (US) 2025-11-27 WO disclosed
US-20250333369-A1 Branched Technologies SCION Holdings LLC (US) 2025-10-30 US disclosed
EP-4622618-A1 PERSONAL CARE COMPOSITIONS FOR CLEANSING THE SKIN The Procter & Gamble Company (US) 2025-10-01 EP disclosed
EP-4161893-B1 ALCOHOLS PRODUCTION SCION Holdings LLC (US) 2025-07-16 EP disclosed
US-20250179388-A1 WATER-SOLUBLE UNIT DOSE ARTICLE PROCTER & GAMBLE (US) 2025-06-05 US disclosed
US-12318465-B2 Personal care compositions for cleansing the skin THE PROCTER & GAMBLE COMPANY (US) 2025-06-03 US disclosed
EP-4532456-A1 BRANCHED TECHNOLOGIES Scion Holdings LLC (US) 2025-04-09 EP disclosed
US-12247183-B2 Water-soluble unit dose article THE PROCTER & GAMBLE COMPANY (US) 2025-03-11 US disclosed
US-20250074849-A1 Branched Products SCION Holdings LLC (US) 2025-03-06 US disclosed
US-20210380510-A1 Branched Compounds SCION Holdings LLC (US) 2021-12-09 US disclosed
EP-3919594-A1 LIQUID HAND DISHWASHING DETERGENT COMPOSITION The Procter & Gamble Company (US) 2021-12-08 EP disclosed
CN-109790284-B Polyphenol compound and process for producing the same 三菱化学株式会社 2021-09-21 CN disclosed
EP-1878787-B1 Aldehydes substituted with alkyls in alpha position as odorous and aroma substances SYMRISE GMBH & CO KG (DE) 2010-09-29 EP disclosed
US-7439403-B2 Aldehydes substituted in alpha position by alkyl residues as odoriferous and aroma substances SYMRISE GMBH & CO. KG (DE) 2008-10-21 US disclosed
US-20080015392-A1 Aldehydes substituted in alpha position by alkyl residues as odoriferous and aroma substances SYMRISE GMBH & CO. KG (DE) 2008-01-17 US disclosed
EP-1878787-A1 Aldehydes substituted with alkyls in alpha position as odorous and aroma substances Symrise GmbH & Co. KG (DE) 2008-01-16 EP disclosed
WO-2006110185-A2 ANTIINFECTIVE LIPOPEPTIDES CUBIST PHARMACEUTICALS, INC. (US) 2006-10-19 WO disclosed
EP-0659725-B1 Process for the preparation of aldehydes substituted by an alkylradical in alpha position HOECHST AG (DE) 1997-05-02 EP disclosed
EP-0659725-A1 Process for the preparation of aldehydes substituted by an alkylradical in alpha position HOECHST AKTIENGESELLSCHAFT (DE) 1995-06-28 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20250333369-A1 Branched Technologies ADH5, ADH1A, ADH1C TSHR 3426/4885SMN1; SMN2 2614/4885ADH1B 58/4885
US-20210380510-A1 Branched Compounds ADH5, ADH1A, ADH1C TSHR 4102/4885SMN1; SMN2 3146/4885ADH1B 123/4885
US-20250074849-A1 Branched Products ADH5, ADH1A, ADH1C TSHR 3783/4885SMN1; SMN2 3283/4885ADH1B 106/4885
US-20080015392-A1 Aldehydes substituted in alpha position by alkyl residues as odoriferous and aroma substances OR10J3, ALDH1A1, CRAT TSHR 3701/4885SMN1; SMN2 3393/4885ADH1B 161/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.